Q3D Visual Diagnostics, LLC

Q3D is a non-invasive medical device for full spectral detection of amblyopia (lazy eye) providing precise detection & treatment monitoring.

  • Stage Product In Development
  • Industry Medical Devices and Equipment
  • Location St. Louis, MO, USA
  • Currency USD
  • Founded February 2012

Company Summary

Q3D Visual Diagnostics LLC is developing a patented, non-invasive ophthalmology device for the full spectral digital measurement of amblyopia (lazy eye). Using this novel device, healthcare professionals can detect mild to severe cases of amblyopia, diagnose the condition much sooner than is currently possible allowing for significantly better health outcomes for children, measure treatment effectiveness, and monitor progression to normal vision.

Team

  • Dan Schmitt
    CEO

    Dan Schmitt is co-founder, Pres., and CEO of AAQ & the founder of The Incubation Factory (TIF). In 2005, he combined his expertise in business development, administration, finance & marketing to create TIF, a privately funded Economic Development Platform. He takes an active role in strategic consulting and business model development of each TIF company & has invested in all of TIF’s companies. Dan has a B.A. in Marketing from U. of Northern Iowa

  • Andy Wolter
    COO

    Andy Wolter is the Executive VP of Operations of for AAQ & TIF. He has served in the U.S. Navy’s Nuclear Program as an officer & later joined GE Appliances as an Advanced Manufacturing Engineer, earning a Master Black Belt in GE’s Six Sigma Quality program. In 2001, he joined GE Capital as an Operations Manager & joined AAQ in 2003 helping shape TIF. He has a degree in Engineering from Iowa State & his MBA from the College of William & Mary.

  • Cindy Schmitt
    CFO

    Cindy Schmitt is the Executive VP of Back Office Services for AAQ & TIF. Her career began with GM Acceptance Corp. leaving as the VP of Bank Relations. She served as Asst. VP of Cash Management with Norwest Corp. & later as VP of Cash Management for GE Capital. She directs all of TIF's back office functions: accounting, legal, HR, compliance & regulatory for TIF & its portfolio. She earned a BA in Accounting from the University of Northern Iowa.

  • RJ Lindmark
    Principal

    RJ Lindmark has over decade of experience as a Research Scientist working at Monsanto/Searle/Pharmacia as a Chemist. After working in the pharmaceutical market, he spent the next 8 years in sales, business development and marketing to the pharmaceutical research market place. He has spent the last 3 years as a Technology Business Analyst for TIF. He has both his BA and MS in Chemistry from Brigham Young University.

Advisors

  • Pixie Goedde
    Accountant
    Unconfirmed

Previous Investors

  • none
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free